Recent Developments in Drug-Eluting Coronary Stents

2014 ◽  
Vol 14 (3) ◽  
pp. 220-224 ◽  
Author(s):  
Mustafa Yildiz ◽  
Banu Yildiz ◽  
Mustafa Gursoy ◽  
Ibrahim Akin
Keyword(s):  
Coronary Stents ◽  
Recent Developments ◽  
Drug Eluting

Deciphering Dual Antiplatelet Therapy in the Era of Drug-Eluting Coronary Stents

2009 ◽  
Vol 10 (6) ◽  
pp. 519-529 ◽  
Author(s):  
Brendan Bell ◽  
Darren Walters ◽  
Christian Spaulding
Keyword(s):  
Antiplatelet Therapy ◽  
Dual Antiplatelet Therapy ◽  
Coronary Stents ◽  
Drug Eluting

scholarly journals Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel and the Risk of Kounis Syndrome

Dermatology ◽  
2009 ◽  
Vol 219 (1) ◽  
pp. 87-88 ◽  
Author(s):  
George D. Soufras ◽  
George N. Kounis ◽  
John A. Chiladakis ◽  
Sophia A. Kounis ◽  
Georgia V. Gouvelou-Deligianni ◽  
...  
Keyword(s):  
Coronary Stents ◽  
Hypersensitivity Reactions ◽  
Kounis Syndrome ◽  
Drug Eluting

A systematic review and economic analysis of drug‐eluting coronary stents available in Australia

2005 ◽  
Vol 183 (9) ◽  
pp. 464-471 ◽  
Author(s):  
Sarah J Lord ◽  
Felicity Allen ◽  
Luke Marinovich ◽  
David C Burgess ◽  
Kirsten Howard ◽  
...  
Keyword(s):  
Systematic Review ◽  
Economic Analysis ◽  
Coronary Stents ◽  
Drug Eluting

scholarly journals The Newest Generation of Drug-eluting Stents and Beyond

2018 ◽  
Vol 13 (1) ◽  
pp. 54 ◽  
Author(s):  
Dae-Hyun Lee ◽  
Jose M de la Torre Hernandez ◽  
◽  
Keyword(s):  
Control Release ◽  
Radial Force ◽  
Coronary Stents ◽  
Drug Eluting Stents ◽  
Optimal Duration ◽  
Drug Eluting ◽  
The Ideal

There has been a great evolution in the development of coronary stents in order to avoid both restenosis and thrombosis. Improvements have led to improvements in the design and conformation of metallic or resorbable structures, with an adequate balance between trackability and radial force, the development of antiproliferative drugs and the polymers to control release and allow adequate endothelialisation and an optimal duration of the antiplatelet regimen. Some suggestions are provided about the ideal characteristics of future coronary stents.

scholarly journals 10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents

2020 ◽  
Vol 76 (2) ◽  
pp. 146-158 ◽  
Author(s):  
Sebastian Kufner ◽  
Maximilian Ernst ◽  
Salvatore Cassese ◽  
Michael Joner ◽  
Katharina Mayer ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Coronary Stents ◽  
Durable Polymer ◽  
Drug Eluting

Determining clinical benefits of drug-eluting coronary stents according to the population risk profile: A meta-regression from 31 randomized trials

2011 ◽  
Vol 148 (1) ◽  
pp. 23-29 ◽  
Author(s):  
Raul Moreno ◽  
Roberto Martin-Reyes ◽  
Santiago Jimenez-Valero ◽  
Angel Sanchez-Recalde ◽  
Guillermo Galeote ◽  
...  
Keyword(s):  
Randomized Trials ◽  
Risk Profile ◽  
Coronary Stents ◽  
Clinical Benefits ◽  
Drug Eluting ◽  
Meta Regression

Molecular imaging of drug-eluting coronary stents: method development, optimization and selected applications

2012 ◽  
Vol 47 (2) ◽  
pp. 155-162 ◽  
Author(s):  
Jiun-Tang Huang ◽  
Li Hannah-Qiuhua ◽  
Renata Szyszka ◽  
Vladimir Veselov ◽  
Gail Reed ◽  
...  
Keyword(s):  
Molecular Imaging ◽  
Method Development ◽  
Coronary Stents ◽  
Drug Eluting
Sign in / Sign up

Export Citation Format

Share Document